Pfizer Gets Canadian Approval For $17B Hospira Takeover
The Canadian Competition Bureau has approved Pfizer Inc.'s takeover of Hospira Inc., bringing the $17 billion deal a step closer to closing, the pharmaceutical giant announced on Friday....To view the full article, register now.
Already a subscriber? Click here to view full article